Arkin Bio Ventures
Asia, Tel Aviv, Israel, Herzliya
Description
Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech and medical device technologies.
Investor Profile
Arkin Bio Ventures has backed more than 19 startups, with 2 new investments in the last 12 months alone. The firm has led 2 rounds, about 11% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, Israel, Canada.
- Strong thematic focus on Biotechnology, Therapeutics, Health Care.
Stage Focus
- Series A (47%)
- Series B (32%)
- Series C (16%)
- Seed (5%)
Country Focus
- United States (84%)
- Israel (11%)
- Canada (5%)
Industry Focus
- Biotechnology
- Therapeutics
- Health Care
- Pharmaceutical
- Medical
- Oncology
- Life Science
- Biopharma
- Mental Health
- Neuroscience
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
